• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏移植受者中的淋巴瘤:抗病毒药物能否预防抗CD3单克隆抗体的致癌作用?

Lymphomas in heart transplant recipients: do antivirals protect against the neoplastic effect of anti-CD3 monoclonal antibody?

作者信息

Sánchez-Lázaro I J, Almenar L, Martínez-Dolz L, Agüero J, Buendía F, Navarro J, Raso R, Salvador A

机构信息

Heart Failure and Transplant Unit, Department of Cardiology, La Fe University Hospital, Valencia, Spain.

出版信息

Transplant Proc. 2010 Oct;42(8):3206-7. doi: 10.1016/j.transproceed.2010.05.128.

DOI:10.1016/j.transproceed.2010.05.128
PMID:20970653
Abstract

INTRODUCTION AND AIM

After cardiac allograft vasculopathy, tumors are the second leading cause of death among heart transplantation (HT) patients after the first year. Lymphomas are tumors of lymphocytic origin whose development has been associated with the use of anti-CD3 monoclonal antibody (OKT3). Some studies suggest that the use of acyclovir could counteract this effect. Our aim was to investigate the impact of gancyclovir on OKT3 and lymphoma development after HT.

MATERIALS AND METHODS

We included all 239 HTs performed in our center from 1989 to 2002. We divided patients into those who received gancyclovir treatment (prophylaxis, pre-emptive therapy, or for cytomegalovirus infection) versus those who did not receive this agent at any time during follow-up (88 vs 151 patients). The statistical methods were Student's t and chi-square tests.

RESULTS

There were no differences in the baseline characteristics of the patients--gender, recipient age, etiology leading to HT, diabetes, and dyslipidemia--except for a higher rate of hypertension among the group who did not receive gancyclovir (73.7 vs 60.2%; P=.03). None of the 7 patients who developed lymphomas during the follow-up received gancyclovir (0 vs 4.6%; P=.040).

CONCLUSIONS

Antivirals may have a relevant role to neutralize potential neoplastic effects (especially lymphomas) associated with the use of OKT3 induction therapy.

摘要

引言与目的

心脏移植血管病变之后,肿瘤是心脏移植(HT)患者术后第一年之后的第二大死亡原因。淋巴瘤是淋巴细胞起源的肿瘤,其发生与抗CD3单克隆抗体(OKT3)的使用有关。一些研究表明,使用阿昔洛韦可以抵消这种效应。我们的目的是研究更昔洛韦对心脏移植术后OKT3及淋巴瘤发生的影响。

材料与方法

我们纳入了1989年至2002年在我们中心进行的所有239例心脏移植手术。我们将患者分为接受更昔洛韦治疗的患者(预防、抢先治疗或用于巨细胞病毒感染)与随访期间未接受该药物治疗的患者(88例对151例)。统计方法采用学生t检验和卡方检验。

结果

患者的基线特征——性别、受者年龄、导致心脏移植的病因、糖尿病和血脂异常——无差异,但未接受更昔洛韦治疗的组中高血压发生率较高(73.7%对60.2%;P = 0.03)。随访期间发生淋巴瘤的7例患者中,无一例接受更昔洛韦治疗(0对4.6%;P = 0.040)。

结论

抗病毒药物可能在中和与使用OKT3诱导治疗相关的潜在肿瘤效应(尤其是淋巴瘤)方面发挥重要作用。

相似文献

1
Lymphomas in heart transplant recipients: do antivirals protect against the neoplastic effect of anti-CD3 monoclonal antibody?心脏移植受者中的淋巴瘤:抗病毒药物能否预防抗CD3单克隆抗体的致癌作用?
Transplant Proc. 2010 Oct;42(8):3206-7. doi: 10.1016/j.transproceed.2010.05.128.
2
Influence of induction therapy, immunosuppressive regimen and anti-viral prophylaxis on development of lymphomas after heart transplantation: data from the Spanish Post-Heart Transplant Tumour Registry.诱导治疗、免疫抑制方案及抗病毒预防对心脏移植后淋巴瘤发生的影响:来自西班牙心脏移植后肿瘤登记处的数据
J Heart Lung Transplant. 2007 Nov;26(11):1105-9. doi: 10.1016/j.healun.2007.08.010.
3
Immunologic monitoring with Orthoclone OKT3 therapy.使用Orthoclone OKT3疗法进行免疫监测。
J Heart Transplant. 1989 Sep-Oct;8(5):371-80.
4
Sparing of first dose effect of monovalent anti-CD3 antibody used in allograft rejection is associated with diminished release of pro-inflammatory cytokines.用于同种异体移植排斥反应的单价抗CD3抗体首剂效应的减轻与促炎细胞因子释放减少有关。
Ther Immunol. 1994 Dec;1(6):325-31.
5
Sensitization to OKT3 monoclonal antibody in heart transplantation: correlation with early allograft loss.心脏移植中对OKT3单克隆抗体的致敏作用:与早期移植物丢失的相关性。
J Heart Lung Transplant. 1991 Mar-Apr;10(2):217-21; discussion 221-2.
6
Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation.联合抗病毒与免疫球蛋白治疗作为心脏移植后预防巨细胞病毒感染的措施。
J Heart Lung Transplant. 1995 Jul-Aug;14(4):659-65.
7
Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.口服更昔洛韦或口服阿昔洛韦预防器官移植受者原发性巨细胞病毒病
Transpl Infect Dis. 2000 Sep;2(3):112-7.
8
OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.OKT3和更昔洛韦治疗可能与肝移植后血清中存在EB病毒有关。
Transpl Int. 2005 Jul;18(7):835-43. doi: 10.1111/j.1432-2277.2005.00145.x.
9
Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.在巨细胞病毒血清学阳性的肝移植受者中,静脉注射更昔洛韦诱导治疗后,口服更昔洛韦与口服阿昔洛韦用于长期预防巨细胞病毒疾病的随机对照试验。
Transplantation. 2003 Jan 27;75(2):229-33. doi: 10.1097/01.TP.0000040601.60276.96.
10
Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation.莫罗单抗-CD3单克隆抗体(OKT3)在心脏移植中的临床经验。
J Heart Transplant. 1989 Jul-Aug;8(4):281-7.